A Conjugate between Lqh-8/6, a Natural Peptide Analogue of Chlorotoxin, and Doxorubicin Efficiently Induces Glioma Cell Death.

Lqh-8/6 apoptosis chlorotoxin click chemistry conjugation doxorubicin glioma cells

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
17 Oct 2022
Historique:
received: 05 09 2022
revised: 10 10 2022
accepted: 11 10 2022
entrez: 27 10 2022
pubmed: 28 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

Natural peptides isolated from animal venoms generally target cell surface receptors with high affinity and selectivity. On many occasions, some of these receptors are over-expressed in cancer cells. Herein, we identified Lqh-8/6 as a natural peptide analog of chlorotoxin, a proven and useful compound for the diagnosis and treatment of glioma. Lqh-8/6 and two other natural analogues were chemically synthesized for the first time and evaluated for their ability to label, detect and prevent glioma growth in vitro. We demonstrate that a biotinylated version of Lqh-8/6 allows both the labeling of glioma cell lines and the detection of glioma in brain sections of glioma allograft Fisher rats. Lqh-8/6 has intrinsic anti-invasive properties but is non-toxic to glioma cells. To confer anti-tumor properties to Lqh-8/6, we chemically coupled doxorubicin to the glioma-targeting peptide using click chemistry. To this end, we successfully chemically synthesized Lqh-8/6-azide and doxorubicin-alkyne without impairing the toxic nature of doxorubicin. The toxin-drug conjugate efficiently promotes the apoptosis of glioma cells in vitro. This example contributes to the concept that animal venom peptides constitute exquisite warheads for delivering toxic chemical conjugates, a parallel to the popular concept of antibody-drug conjugates for the treatment of cancer.

Identifiants

pubmed: 36289865
pii: biomedicines10102605
doi: 10.3390/biomedicines10102605
pmc: PMC9599068
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Agence Nationale de la Recherche
ID : ANR-11-LABX-0015

Références

Biochem J. 2004 Mar 15;378(Pt 3):717-26
pubmed: 14674883
Mol Pharm. 2015 Dec 7;12(12):4336-48
pubmed: 26465677
Handb Clin Neurol. 2016;134:381-97
pubmed: 26948367
Lancet. 2003 Jan 25;361(9354):323-31
pubmed: 12559880
Biochem Biophys Res Commun. 2010 Jun 11;396(4):908-14
pubmed: 20457128
Lancet Oncol. 2009 May;10(5):459-66
pubmed: 19269895
Cancer Lett. 2010 May 28;291(2):158-66
pubmed: 19906483
Apoptosis. 2009 Nov;14(11):1352-65
pubmed: 19731037
Forum (Genova). 2003;13(1):61-75
pubmed: 14732888
Biochem Biophys Res Commun. 2010 Jan 1;391(1):419-25
pubmed: 19914216
Cell Mol Immunol. 2018 Aug;15(8):737-739
pubmed: 29553137
ACS Nano. 2010 Aug 24;4(8):4587-94
pubmed: 20731441
Neuroscience. 1998 Apr;83(4):1161-73
pubmed: 9502255
J Mater Chem B. 2016 Jan 7;4(1):32-36
pubmed: 26835125
J Neurosci. 1999 Jul 15;19(14):5942-54
pubmed: 10407033
Int J Biochem Cell Biol. 2016 Aug;77(Pt A):15-22
pubmed: 27210502
Cancer Chemother Pharmacol. 1991;29(2):105-11
pubmed: 1760851
J Biol Chem. 2010 Feb 12;285(7):4366-74
pubmed: 20018898
PLoS One. 2011;6(7):e22284
pubmed: 21811581
Toxicon. 1991;29(11):1403-8
pubmed: 1726031
Nano Lett. 2005 Jun;5(6):1003-8
pubmed: 15943433
Small. 2009 Feb;5(2):256-64
pubmed: 19089837
J Neurosci. 2003 Jul 2;23(13):5572-82
pubmed: 12843258
Cancer Lett. 2009 Nov 18;285(1):28-38
pubmed: 19523755
Mol Pharm. 2011 Apr 4;8(2):375-86
pubmed: 21241067
J Inorg Biochem. 2012 May;110:58-63
pubmed: 22465700
Am J Physiol. 1993 Feb;264(2 Pt 1):C361-9
pubmed: 8383429
J Med Chem. 2010 Apr 8;53(7):2814-24
pubmed: 20210346
Cancer J. 2012 Jan-Feb;18(1):26-31
pubmed: 22290254
Glia. 2002 Aug;39(2):162-73
pubmed: 12112367
J Biol Chem. 2003 Feb 7;278(6):4135-44
pubmed: 12454020
Cancer Res. 2007 Jul 15;67(14):6882-8
pubmed: 17638899
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
Anticancer Res. 2015 Mar;35(3):1229-35
pubmed: 25750269
Biochim Biophys Acta. 2014 Oct;1843(10):2356-64
pubmed: 24667409
Cancer Res. 1998 Nov 1;58(21):4871-9
pubmed: 9809993
Sci Rep. 2016 Feb 02;6:19799
pubmed: 26831010
Peptides. 2011 Apr;32(4):656-63
pubmed: 21262299
Technol Cancer Res Treat. 2008 Dec;7(6):497-516
pubmed: 19044329
Ann Oncol. 2012 Sep;23 Suppl 10:x33-40
pubmed: 22987986
Mol Pharmacol. 2000 Apr;57(4):679-86
pubmed: 10727512
J Med Chem. 2006 Nov 16;49(23):6908-16
pubmed: 17154520
J Med Chem. 2011 Feb 10;54(3):782-7
pubmed: 21210710
Int J Mol Sci. 2015 Nov 19;16(11):27730-40
pubmed: 26610471
Nature. 2018 Aug;560(7717):243-247
pubmed: 30069053
Cancer Res. 2013 Jan 15;73(2):804-12
pubmed: 23151901
Acta Neurochir (Wien). 2011 Jun;153(6):1211-8
pubmed: 21479583
Curr Top Med Chem. 2015;15(13):1196-208
pubmed: 25858130
Cancer Cell. 2009 Dec 8;16(6):510-20
pubmed: 19962669
Sci Transl Med. 2010 Jun 2;2(34):34ps26
pubmed: 20519716
Mol Neurobiol. 2020 May;57(5):2461-2478
pubmed: 32152825
Front Oncol. 2015 Jan 29;5:12
pubmed: 25688335
Pharm Res. 2009 Apr;26(4):836-45
pubmed: 19083085
J Neurooncol. 2012 May;107(3):457-62
pubmed: 22108716
ACS Nano. 2016 Feb 23;10(2):2509-20
pubmed: 26745323
Neurosurg Clin N Am. 2021 Jan;32(1):1-8
pubmed: 33223018
Biomaterials. 2011 Mar;32(9):2399-406
pubmed: 21185076
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Biomaterials. 2009 Feb;30(4):649-57
pubmed: 18990439
Eur J Biochem. 1997 May 15;246(1):218-27
pubmed: 9210487
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W485-91
pubmed: 19443448
Toxins (Basel). 2015 Mar 27;7(4):1079-101
pubmed: 25826056
Bioorg Med Chem Lett. 2005 Nov 15;15(22):5071-5
pubmed: 16168650

Auteurs

Lucie Dardevet (L)

L'institut du Thorax, Nantes Université, CNRS, INSERM, 44000 Nantes, France.
LabEx "Ion Channels, Science & Therapeutics", 06560 Valbonne, France.

Feten Najlaoui (F)

Laboratoire des Venins et Biomolécules Thérapeutiques LR11IPT08, Institut Pasteur de Tunis, Tunis 1002, Tunisia.

Sonia Aroui (S)

Laboratory of Biochemistry, Molecular Mechanisms and Diseases Research Unit, UR12ES08, Faculty of Medicine, University of Monastir, Monastir 09023, Tunisia.

Mayeul Collot (M)

Laboratoire de Bioimagerie et Pathologies, UMR CNRS 7021, 74 route du rhin, CS 60024, 67401 Illkirch, France.

Céline Tisseyre (C)

LabEx "Ion Channels, Science & Therapeutics", 06560 Valbonne, France.
Université Grenoble Alpes, 621 Avenue Centrale, 38400 Saint-Martin d'Hères, France.

Michael W Pennington (MW)

Ambiopharm Inc., 1024 Dittman Crt, North Augusta, SC 29842, USA.

Jean-Maurice Mallet (JM)

Laboratoire des Biomolécules, Ecole Normale Supérieure, PSL University, Sorbonne University, CNRS UMR 7203, 75005 Paris, France.

Michel De Waard (M)

L'institut du Thorax, Nantes Université, CNRS, INSERM, 44000 Nantes, France.
LabEx "Ion Channels, Science & Therapeutics", 06560 Valbonne, France.
Smartox Biotechnology, 6 rue des Platanes, 38120 Saint-Egrève, France.

Classifications MeSH